Senzo Health Limited
12170353
Some Concerns
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 22/09/2021
VP BIOASSAY DEVELOPMENT
BRITISH · ENGLAND · Age 50
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr Aron Robert Rachamim
Ceased 20/06/2022
Charges1 outstanding
BIOADVANCE (101 WEST ELM STREET, SUITE 330 CONSHOHOCKEN, PA 19428, USA)
CompanyRankvs 1099+ SIC 72110 peers51
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£4.8M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£4.8M
Working capital
Current Assets
£101k
Current Liabilities
£4.9M
Fixed Assets
£42k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.02 | +£490k |
| 2024 | 0.08 | +£685k |
| 2023 | 0.10 | +£213k |
| 2023 | 0.09 | +£1.2M |
| 2022 | 0.19 | +£1.5M |
| 2021 | 0.91 | +£527k |
| 2021 | 0.77 | -£59k |
| 2020 | 0.30 | +£224k |
| 2020 | -0.58 | +£97k |
| 2020 | -1.15 | — |
Derived from filed accounts. Not audited figures.